Laboratory Freezers Market

The laboratory freezers market is projected to grow from USD 4.32 billion in 2026 to USD 5.11 billion by 2031, at a CAGR of 3.5% during this period. The laboratory freezers market is witnessing strong growth due to the rapid expansion of biopharmaceutical research, precision medicine, cell and gene therapy, and biobanking activities worldwide. Increasing investments in vaccine development, clinical trials, and life science research have significantly increased the demand for reliable ultra-low-temperature (ULT) and cryogenic freezers capable of preserving sensitive biological samples, reagents, and pharmaceuticals. In addition, the establishment of new research laboratories, diagnostic centers, and biorepositories, particularly across emerging economies in Asia Pacific, is creating sustained demand for advanced laboratory cold storage solutions.

Another key growth trend is the adoption of smart, energy-efficient laboratory freezers equipped with IoT-enabled remote monitoring, cloud-based temperature tracking, predictive maintenance, and automated alarm systems to ensure regulatory compliance and sample integrity. Manufacturers are increasingly developing environmentally sustainable freezers that use low-global-warming-potential refrigerants while reducing energy consumption and operating costs. Furthermore, the integration of digital laboratory management systems and automation technologies is improving freezer performance, inventory management, and operational efficiency, supporting the growing demand from pharmaceutical companies, hospitals, academic research institutes, and biotechnology organizations.

To know about the assumptions considered for the study download the pdf brochure

The major players in the laboratory freezers market include Thermo Fisher Scientific (US), Haier Biomedical (China), and Eppendorf AG (Germany), among others. The competitive landscape involves analyzing the key growth strategies adopted by these major players from 2022 to 2026 to expand their global presence and increase their market share. The main growth strategies used by leading companies in this market include product approvals and launches, acquisitions, collaborations, partnerships, and agreements. Over the past three years, product approvals and launches have been the most popular organic growth strategies adopted by market players seeking to increase their share of the market.  

Thermo Fisher Scientific (US)

Thermo Fisher Scientific Inc. is a provider of scientific instruments, laboratory equipment, analytical technologies, and life sciences solutions, serving pharmaceutical and biotechnology companies, academic and research institutions, hospitals, clinical laboratories, and government organizations. In the laboratory freezers market, the company offers a comprehensive portfolio of cold storage solutions under its Thermo Scientific brand, including ultra-low-temperature (ULT) freezers, biomedical freezers, explosion-proof freezers, plasma freezers, and enzyme storage systems. These products are designed to support the secure storage of biological samples, vaccines, pharmaceuticals, blood products, reagents, and other temperature-sensitive materials across research, clinical, and industrial applications.

The company maintains a strong global presence through its extensive manufacturing, distribution, and service network spanning North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Thermo Fisher differentiates its laboratory freezer portfolio by integrating advanced temperature control technologies, energy-efficient refrigeration systems, smart monitoring capabilities, and digital connectivity that enable remote equipment management and regulatory compliance. Supported by continuous investment in research and development, strategic acquisitions, and a broad life sciences ecosystem, the company remains a leading supplier of laboratory cold storage equipment, benefiting from increasing demand for biobanking, cell and gene therapy, vaccine storage, pharmaceutical R&D, and precision medicine worldwide.

Haier Biomedical (China)

Haier Biomedical is a manufacturer of biomedical cold chain equipment and laboratory storage solutions, providing products and integrated cold chain systems for healthcare, life sciences, biotechnology, pharmaceutical, clinical, and research applications. In the laboratory freezers market, the company offers a broad portfolio that includes ultra-low-temperature (ULT) freezers, biomedical freezers, plasma freezers, blood bank refrigerators, vaccine storage units, cryogenic storage systems, and intelligent cold storage solutions. Its products are designed to ensure reliable preservation of biological samples, vaccines, pharmaceuticals, blood products, and other temperature-sensitive materials, supporting laboratories, hospitals, biobanks, universities, and public health institutions worldwide.

The company has established a strong international presence through an expanding manufacturing base, global sales network, and distribution channels across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Haier Biomedical differentiates itself by integrating IoT-enabled monitoring, cloud-based cold chain management, intelligent inventory systems, and energy-efficient refrigeration technologies into its laboratory freezer portfolio. The company continues to strengthen its position through ongoing product innovation, investments in smart laboratory infrastructure, and expansion into emerging life sciences and biopharmaceutical markets, benefiting from rising demand for biobanking, vaccine storage, cell and gene therapy research, and precision medicine applications.

 Eppendorf AG (Germany)

Eppendorf AG is a life science company specializing in laboratory instruments, consumables, and workflow solutions for academic research, biotechnology, pharmaceutical, clinical, and industrial laboratories. In the laboratory freezers market, the company offers a range of ultra-low-temperature (ULT) freezers and laboratory freezers under the Eppendorf brand, designed for the safe and reliable storage of biological samples, reagents, enzymes, vaccines, cell cultures, and other temperature-sensitive materials. Its cold storage portfolio emphasizes precise temperature uniformity, sample integrity, energy efficiency, and user-friendly operation, supporting applications in molecular biology, microbiology, cell biology, biobanking, and pharmaceutical research.

Eppendorf has a strong global footprint, with manufacturing facilities, subsidiaries, and distribution partners serving customers across Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa. The company strengthens its position in the laboratory freezers market through continuous investment in product innovation, sustainable refrigeration technologies, and digital monitoring capabilities that improve operational efficiency and regulatory compliance. By leveraging its broad portfolio of laboratory equipment—including centrifuges, pipetting systems, incubators, and bioprocess solutions—Eppendorf provides integrated laboratory workflows, enabling it to maintain a strong presence in research laboratories, healthcare institutions, and biopharmaceutical manufacturing facilities worldwide.

Market Ranking:

The laboratory freezers market is characterized by the presence of several global manufacturers, with Thermo Fisher Scientific (US), Haier Biomedical (China), and Eppendorf AG (Germany) accounting for a significant share of the market through their extensive product portfolios, strong global distribution networks, and continuous investments in product innovation. These companies offer a wide range of ultra-low-temperature (ULT) freezers, biomedical freezers, plasma freezers, and specialized cold storage systems designed for pharmaceutical companies, biotechnology firms, hospitals, clinical laboratories, academic institutions, and biobanks. Their competitive advantage is driven by advanced temperature control technologies, energy-efficient refrigeration systems, digital monitoring capabilities, and comprehensive after-sales service.

Related Reports:

Laboratory Freezers Market by Modality (Cryopreservation; Freezer: ULTF, Plasma, Enzyme; Refrigerator: Blood Bank, Pharmacy, Chromatography), Application (Genetic, Vaccine, Biological Sample), End User (Hospital, Pharma, Cell Bank)-Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]